A unified platform that brings together clinical data, analytics, and workflows, enabling care teams to operate with clarity, efficiency, and confidence.
Built for health systems, ACOs, and academic medical centers.
Core Capabilities
One platform. Three powerful modules.
01Patient Intelligence
01 / 03
Patient Intelligence
Understand every patient's full clinical picture in seconds. Labs, vitals, medications, and history synthesized by AI.
JM
John Mitch
Acute Myeloid Leukemia
High Risk
WBC
4.0
Temp
101.8°F
Hgb
8.2
AI Clinical Summary
Febrile neutropenia identified. WBC trending down post-chemo with persistent fever. Immediate intervention recommended.
Patient Timeline — John Mitch
Mar 2025
Febrile neutropenia — ER admission
WBC 4.0, Temp 101.8°F
Feb 2025
Chemo cycle 3 — Cytarabine + Daunorubicin
WBC dropped to 2.1
Dec 2024
Bone marrow biopsy — partial remission
Sep 2023
Initial AML diagnosis — induction chemo started
Zoom: 2Y6M1M
White Blood Cells (WBC)
Below normal
4.0 x10³/µL
Normal range: 4.5 – 11.0
NovDecJanFebNow
Contextual Interpretation
WBC at 4.0 appears near-normal but is clinically significant given active chemotherapy, persistent fever (101.8°F), and declining trend over 4 months.
Dr
Plot WBC and temperature between Sep 2023 and Mar 2025
WBC vs Temperature — Sep 2023 to Mar 2025
WBCTemp
WBC shows steady decline correlating with chemotherapy cycles. Temperature spikes inversely correspond with WBC nadirs.
Clinical References — Febrile Neutropenia
IDSA Guidelines: Febrile Neutropenia Management
Freifeld et al. — Clinical Infectious Diseases, 2011
PubMed · PMID: 21258094
Risk stratification in febrile neutropenia: MASCC score
Klastersky et al. — J Clin Oncology, 2000
PubMed · PMID: 10944126
AML treatment-related mortality and infection risk
Bow et al. — Haematologica, 2019
PubMed · PMID: 30872368
References sourced from PubMed and OpenEvidence, linked to this patient's clinical context.
02Population Intelligence
02 / 03
Population Intelligence
Identify, stratify, and act on entire patient cohorts at once, with plain language, not SQL, and instant results.
Create a new cohort
Patients with type 2 diabetes in clinic 112 SNDE and 123 Labo
AI-Generated Criteria
IncludeICD-10: E11.x (Type 2 Diabetes)
IncludeClinic: 112 SNDE or 123 Labo
ExcludeDeceased patients
242 patients matched · Ready to create
Risk Categorization Rules
Urgent
• HbA1c ≥ 10%
• eGFR < 30 mL/min (Stage 4+ CKD)
• 2+ missed appointments in 6 months
View clinical rationale →
Monitor
• HbA1c 8–10% • 1 missed appt • New comorbidity
Stable
• HbA1c < 8% • Regular follow-up • No new complications
Cohort: Type 2 Diabetes · Live
12
Urgent
47
Monitor
183
Stable
M. Tremblay — HbA1c 11.2%, 2 missed appts
S. Chen — eGFR declining, HbA1c 9.8%
L. Bouchard — HbA1c 8.5%, new retinopathy
Auto-updated 2 min ago · Next refresh in 13 min
MT
M. Tremblay
Type 2 Diabetes · Urgent
Why flagged as Urgent
HbA1c11.2%threshold: ≥10%
Missed appts2threshold: ≥2
eGFR42declining trend
Data sourced from labs (Feb 2025), scheduling system, and renal panel history.
12 urgent patients selected
Select all urgent
M. TremblayUrgent
S. ChenUrgent
R. GagnonUrgent
03Smart Note-Taking
03 / 03
Smart Note-Taking
Capture encounters by voice, keyboard, or import, and get a structured, coded clinical note ready to validate in one click.
VoiceKeyboardImport
"Patient presents with persistent cough for 2 weeks, low-grade fever. History of COPD..."
Structured Note (Progress Note)
DxAcute exacerbation of COPD (J44.1)
RxPrednisone 40mg x 5d, Azithromycin
PlanChest X-ray, follow-up in 7 days
Auto-Coded Clinical Concepts
Patient presents with persistent cough R05.9 for 2 weeks, low-grade fever R50.9. History of COPD J44.1. Currently on Tiotropium and Albuterol PRN.
Detected ICD-10 Codes
J44.1 COPD w/ exacerbationR50.9 FeverR05.9 Cough
Differential Diagnosis
87%
Acute exacerbation of COPD
Persistent cough, fever, COPD history
+
42%
Community-acquired pneumonia
Fever, cough, possible infiltrate
+
15%
Acute bronchitis
Cough duration, low-grade fever
−
Care Plan — Ready for Validation
Rx: Prednisone 40mg x 5 daysPrescription
Rx: Azithromycin 500mg + 250mg x 4Prescription
Chest X-ray (PA + lateral)Exam
Follow-up in 7 daysTask
Progress Note — Editable
UndoRedoRe-record
Chief Complaint
Persistent cough x 2 weeks with low-grade fever.
Assessment
Acute exacerbation of COPD (J44.1). Consider sputum culture if no improvement in 48h.
Plan
Prednisone 40mg x 5d, Azithromycin, CXR, f/u 7 days.
How It Works
Built for the moment of care, not after the fact
Medeloop Care lives inside the clinician's existing workflow, surfacing insights at the point of decision, not hours later in a separate tool.
01·Launch
Launches inside the patient chart
Care opens natively from your EMR with a single click. No new login, no new tab, no workflow disruption. Clinicians stay exactly where they already work.
Native EMR integration: one-click access from the chart
No data duplication or separate systems to maintain
Secure, HIPAA-compliant integration
your-ehr.health
SM
Sarah M. · 58F
MRN 0012345 · Ward 4 · Admitted 3d ago
High Risk
Summary
Notes
Labs
Orders
Open Medeloop
Medeloop Care · Launched
AI Clinical Summary
Reading patient history, labs, notes, and vitals…
02·Understand
The full patient picture, instantly
AI reads notes, labs, meds, vitals, devices, and history, synthesizing everything into a structured, clinician-ready view in seconds.
Clinical summaries generated from the full patient record
Risk signals and care gaps surfaced automatically
Every insight traceable to the source data
Data enrichment
Clinical History
Lab Trends
Medications
Risk Signals
AI-structured · Ready for review
03·Act
Clinician decides, always
Recommendations, risk signals, and care gaps are surfaced with full reasoning. Review, edit, and approve; the clinician stays in control.
Next-best-action recommendations, not black-box outputs
Every suggestion reviewable, editable, and explainable
Clinician approval required before anything is executed
